Researchers at IIT Roorkee have developed a new antibody discovery platform that could greatly improve medical testing and treatment. The new system is designed to find useful antibodies much faster than current methods, helping doctors and scientists respond quickly to diseases.
The platform is based on a very large and diverse nanobody library. Nanobodies are small, strong antibodies that can bind tightly to disease targets. Using this library, researchers can quickly identify highly stable and high-affinity antibodies for diseases such as infections, cancer, autoimmune disorders, and newly emerging pathogens.
One of the biggest benefits of this platform is speed. It significantly cuts down the time needed to discover antibodies. This is especially important during health emergencies like pandemics, where quick and accurate diagnosis can save lives.
Prof. Rajesh Kumar from IIT Roorkee said the platform will help India respond faster to diseases and develop affordable diagnostic and treatment tools. He added that building such technology in India strengthens national healthcare capabilities and reduces dependence on foreign products.
The project supports the goals of Atmanirbhar Bharat and Make in India. It is also important for low- and middle-income countries, where access to fast and low-cost healthcare solutions is often limited.
IIT Roorkee Director Prof. K. K. Pant said the work shows how basic research, when combined with real-world application and industry support, can solve major social problems. The research also helps build long-term healthcare strength and better preparation for future pandemics.
To ensure the technology reaches hospitals and labs, IIT Roorkee has partnered with industry. The institute has signed an agreement with IMGENEX India to support further research, testing, and large-scale production.
This collaboration will help develop advanced diagnostic tools and treatments, making modern healthcare more accessible and affordable for many people.
